Pharmaron Signs CMO Contract with Isis Pharma

Pharmaron, a Beijing-based CRO/CMO, will provide Isis Pharmaceuticals with up to 100 kg. of nucleoside phosphoramidites. Isis is developing antisense drugs – it has a pipeline of 24 molecules in development – and nucleoside phosphoramidites are the fundamental building blocks used to produce antisense therapeutics. The agreement is a two-year contract. Pharmaron has been providing materials for Isis during its early discovery work. More details.... Stock Symbol: (NSDQ: ISIS)     Share this with colleagues:   var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});